05:51 PM EDT, 04/17/2024 (MT Newswires) -- Samarth Kulkarni, Director, Chief Executive Officer, on April 15, 2024, sold 19,582 shares in Crispr Therapeutics ( CRSP ) for $1,173,232. Following the Form 4 filing with the SEC, Kulkarni has control over a total of 408,122 shares of the company, with 208,122 shares held directly and 200,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1674416/000095017024045196/xslF345X03/ownership.xml